We’re delighted to add a summary of a recent event titled: Change of mode of action after monoclonal antibody exposure: the role of XP01 in multiple myeloma today.
The presentation highlights three presentations which were given virtually at the European Hematology Association Congress in June. The presenters were Dr Meletios Dimopoulos, Dr Maximilian Merz and Dr Elias Mai. Additional commentary is provided by Dr Adam Bryant, Senior Staff Specialist at Liverpool Hospital.
Please login below to download this issue (PDF)